Skip to main content

Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure.

Publication ,  Conference
Dixon, BS; Greene, T; Beck, GJ; Dember, LM; Gassman, JJ; Himmelfarb, J; Hunsicker, LG; Kaufman, J; Kusek, JW; Middleton, JP; Schwab, SJ; Feldman, HI
Published in: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
September 1, 2002

Duke Scholars

Published In

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

ISSN

1046-6673

Publication Date

September 1, 2002

Volume

13

Start / End Page

232A / 232A

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dixon, B. S., Greene, T., Beck, G. J., Dember, L. M., Gassman, J. J., Himmelfarb, J., … Feldman, H. I. (2002). Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure. In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (Vol. 13, pp. 232A-232A). LIPPINCOTT WILLIAMS & WILKINS.
Dixon, B. S., T. Greene, G. J. Beck, L. M. Dember, J. J. Gassman, J. Himmelfarb, L. G. Hunsicker, et al. “Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure.” In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13:232A-232A. LIPPINCOTT WILLIAMS & WILKINS, 2002.
Dixon BS, Greene T, Beck GJ, Dember LM, Gassman JJ, Himmelfarb J, et al. Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure. In: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2002. p. 232A-232A.
Dixon, B. S., et al. “Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure.JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 13, LIPPINCOTT WILLIAMS & WILKINS, 2002, pp. 232A-232A.
Dixon BS, Greene T, Beck GJ, Dember LM, Gassman JJ, Himmelfarb J, Hunsicker LG, Kaufman J, Kusek JW, Middleton JP, Schwab SJ, Feldman HI. Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2002. p. 232A-232A.

Published In

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

ISSN

1046-6673

Publication Date

September 1, 2002

Volume

13

Start / End Page

232A / 232A

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences